The Trump Administration’s Response to the Drug Crisis, Part II
Meeting Status:
Scheduled
Date:
Location:
Capitol Complex, 2154 RHOB, Washington, DC, 20515, USA
SUBCOMMITTEE CHAIRMAN CONNOLLY'S OPENING STATEMENT
PURPOSE
The hearing will examine ONDCPâs coordination of national drug control efforts, including the Administrationâs response to the opioid crisis. The hearing will also examine ONDCPâs implementation of the provisions of the SUPPORT for Patients and Communities Act that reauthorized the agency.
Witnesses
WITNESSES
The Honorable James W. Carroll Jr.
Director
Office of National Drug Control Policy
Triana McNeil
Acting Director, Homeland Security and Justice
Government Accountability Office
Karyl Thomas Rattay, M.D., M.S.
Director
Delaware Division of Public Health
Sheriff Wayne Ivey
Brevard County, Florida
Meeting Documents
Issues:
Opioids